.png?width=1200&height=630&name=Transformation%20in%20therapy%20delivery%20(1).png)
Rethinking how therapies reach patients
Therapy delivery is changing fast. Policy, more complex therapies and a shrinking pharmacy network are pushing pharma and MedTech companies to rethink how their therapies reach patients. The right delivery model keeps your organisation efficient, compliant and patient-centric.
What the mini-guide covers
-
Drivers of change: policy pressure, more complex therapies, a changing pharmacy landscape, patient expectations and economic pressure.
-
Delivery models: wholesale, direct-to-pharmacy, direct-to-patient and retail, and what each one means for control and margin.
-
Segmentation: using order data to align your commercial strategy with customer segments, products and channels.
-
Internal impact: what changes for supply chain, customer service, finance, IT, pricing and compliance.
Direct delivery gives you more control, margin and data. It also shifts work to departments that are often not ready for it. A practical case shows how Möbius helped a pharmaceutical company compare delivery scenarios. Together they chose the model with the best balance between patient access, feasibility and regulatory requirements.
From strategy to implementation
The mini-guide ends with a six-step roadmap, from strategic preparation to a phased roll-out. Use it to see where your organisation stands and which steps need attention first.
